The DOI matches its Crossref record; 153 of the 154 references it cites were found in a registry or an index.
Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases
Open accessAbstract
Many neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis, are characterized by the progressive appearance of abnormal proteinaceous assemblies in the nervous system. Studies in experimental systems indicate that the assemblies originate from the prion-like seeded aggregation of specific misfolded proteins that proliferate and amass to form the intracellular and/or extracellular lesions typical of each disorder. The host in which the proteopathic seeds arise provides the biochemical and physiological environment that either supports or restricts their emergence, proliferation, self-assembly, and spread. Multiple mechanisms influence the spatiotemporal spread of seeds and the nature of the resulting lesions, one of which is the cellular uptake, release, and transport of seeds along neural pathways and networks. The characteristics of cells and regions in the affected network govern their vulnerability and thereby influence the neuropathological and clinical attributes of the disease. The propagation of pathogenic protein assemblies within the nervous system is thus determined by the interaction of the proteopathic agent and the host milieu.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This triphasic framework is also shared by other NDDs, such as amyotrophic lateral sclerosis [4,5].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The pathogenesis of AD, PD, and HD can conceptually be broken down into three phases: (1) creation of an abnormal protein, (2) aggregation or lack of clearance, and (3) propagation.”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [5]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
Keren-Shaul, H., Spinrad, A., Weiner, A., Matcovitch-Natan, O., Dvir-Szternfeld, R., Ulland, T. K., David, E., Baruch, K., Lara-Astaiso, D., Toth, B., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.018 · Cited by 5,493
The distribution of secondary growths in cancer of the breast.
Paget, S. (1889) · The Lancet · doi:10.1016/s0140-6736(00)49915-0 · Cited by 5,277
Novel Proteinaceous Infectious Particles Cause Scrapie
Prusiner, S. B. (1982) · Science · doi:10.1126/science.6801762 · Cited by 5,221
Jack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396
Parkinson, J. (2002) · Journal of Neuropsychiatry · doi:10.1176/jnp.14.2.223 · Cited by 2,856
Luk, K. C., Kehm, V., Carroll, J., Zhang, B., O’Brien, P., Trojanowski, J. Q., & Lee, V. M.-Y. (2012) · Science · doi:10.1126/science.1227157 · Cited by 2,563
The spectrum of disease in chronic traumatic encephalopathy
McKee, A. C., Stein, T. D., Nowinski, C. J., Stern, R. A., Daneshvar, D. H., Alvarez, V. E., Lee, H.-S., Hall, G., Wojtowicz, S. M., Baugh, C. M., et al. (2013) · Brain · doi:10.1093/brain/aws307 · Cited by 2,098
Cryo-EM structures of tau filaments from Alzheimer’s disease
Fitzpatrick, A. W. P., Falcon, B., He, S., Murzin, A. G., Murshudov, G., Garringer, H. J., Crowther, R. A., Ghetti, B., Goedert, M., & Scheres, S. H. W. (2017) · Nature · doi:10.1038/nature23002 · Cited by 2,061
Cited by
Sorted by citations
Synergy between amyloid-β and tau in Alzheimer’s disease
Busche, M. A., & Hyman, B. T. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-0687-6 · Cited by 1,242
Dominantly Inherited Alzheimer Network, Preische, O., Schultz, S. A., Apel, A., Kuhle, J., Kaeser, S. A., Barro, C., Gräber, S., Kuder-Buletta, E., LaFougere, C., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0304-3 · Cited by 927
Self-citationLiquid–Liquid Phase Separation in Disease
Alberti, S., & Dormann, D. (2019) · Annual Review of Genetics · doi:10.1146/annurev-genet-112618-043527 · Cited by 871
Nguyen, P. H., Ramamoorthy, A., Sahoo, B. R., Zheng, J., Faller, P., Straub, J. E., Domínguez, L., Shea, J., Dokholyan, N. V., Simone, A. D., et al. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01122 · Cited by 680
Cryo-EM structure and polymorphism of Aβ amyloid fibrils purified from Alzheimer’s brain tissue
Kollmer, M., Close, W., Funk, L., Rasmussen, J., Bsoul, A., Schierhorn, A., Schmidt, M., Sigurdson, C. J., Jucker, M., & Fändrich, M. (2019) · Nature Communications · doi:10.1038/s41467-019-12683-8 · Cited by 608
Self-citationGut microbiota and dysbiosis in Alzheimer's disease: Implications for pathogenesis and treatment
Liu, S., Gao, J., Zhu, M., Liu, K., & Zhang, H.-L. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02073-3 · Cited by 516
“Through a mechanism very similar to that of prion molecules, Aβ may seed in the brain from neuron to neuron, contributing to the progression of cytopathological lesions in AD [72].”
BackgroundJo, M., Lee, S., Jeon, Y., Kim, S., Kwon, Y., & Kim, H. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00513-7 · Cited by 427
Alzheimer's disease: From immunotherapy to immunoprevention
Jucker, M., & Walker, L. C. (2023) · Cell · doi:10.1016/j.cell.2023.08.021 · Cited by 353
Self-citationMicroglia in Alzheimer's disease at single-cell level. Are there common patterns in humans and mice?
Chen, Y., & Colonna, M. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20202717 · Cited by 339
α-Synuclein strains target distinct brain regions and cell types
Lau, A., So, R. W. L., Lau, H. H. C., Sang, J. C., Ruiz‐Riquelme, A., Fleck, S. C., Stuart, E., Menon, S. A., Visanji, N. P., Meisl, G., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0541-x · Cited by 316
Initiation and propagation of α-synuclein aggregation in the nervous system
Hijaz, B. A., & Volpicelli‐Daley, L. A. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00368-6 · Cited by 283
The human connectome in Alzheimer disease — relationship to biomarkers and genetics
Yu, M., Sporns, O., & Saykin, A. J. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-021-00529-1 · Cited by 265
Mechanisms and pathology of protein misfolding and aggregation
Louros, N. N., Schymkowitz, J. W. H., & Rousseau, F. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00647-2 · Cited by 271
Feng, Z., Chen, X., Wu, X., & Zhang, M. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.rev119.007895 · Cited by 244
Amyloid-type Protein Aggregation and Prion-like Properties of Amyloids
Willbold, D., Strodel, B., Schroeder, G. F., Hoyer, W., & Heise, H. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00196 · Cited by 226
Chidambaram, S. B., Essa, M. M., Rathipriya, A. G., Bishir, M., Ray, B., Mahalakshmi, A. M., Tousif, A. H., Sakharkar, M. K., Kashyap, R. S., Friedland, R. P., et al. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107988 · Cited by 204
Calcium Dyshomeostasis in Alzheimer’s Disease Pathogenesis
Cascella, R., & Cecchi, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094914 · Cited by 194
Peering into tunneling nanotubes—The path forward
Cervantes, D. C., & Zurzolo, C. (2021) · The EMBO Journal · doi:10.15252/embj.2020105789 · Cited by 175
Amyloid β-protein and beyond: the path forward in Alzheimer’s disease
Walsh, D. M., & Selkoe, D. J. (2020) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2020.02.003 · Cited by 164
Vogel, J. W., Corriveau‐Lecavalier, N., Franzmeier, N., Pereira, J. B., Brown, J. A., Maaß, A., Botha, H., Seeley, W. W., Bassett, D. S., Jones, D. T., et al. (2023) · Nature reviews. Neuroscience · doi:10.1038/s41583-023-00731-8 · Cited by 180
Koszła, O., & Sołek, P. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01791-8 · Cited by 164
Spatial Patterning of Tissue Volume Loss in Schizophrenia Reflects Brain Network Architecture
Shafiei, G., Markello, R. D., Makowski, C., Talpalaru, A., Kirschner, M., Devenyi, G. A., Guma, E., Hagmann, P., Cashman, N. R., Lepage, M., et al. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.09.031 · Cited by 152
Canine Cognitive Dysfunction and Alzheimer’s Disease – Two Facets of the Same Disease?
Mihevc, S. P., & Majdič, G. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00604 · Cited by 152
Chen, C., Zhou, Y., Wang, H., Alam, A. M., Kang, S. S., Ahn, E. H., Liu, X., Jia, J., & Ye, K. (2021) · The EMBO Journal · doi:10.15252/embj.2020106320 · Cited by 138
Alpha-Synuclein: Mechanisms of Release and Pathology Progression in Synucleinopathies
Brás, I. C., & Outeiro, T. F. (2021) · Cells · doi:10.3390/cells10020375 · Cited by 136
Vaquer‐Alicea, J., Diamond, M. I., & Joachimiak, Ł. A. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02301-7 · Cited by 139
Transgenic Mouse Models of Alzheimer’s Disease: An Integrative Analysis
Sanchez-Varo, R. M., Mejias‐Ortega, M., Fernandez-Valenzuela, J. J., Nuñez‐Diaz, C., Cáceres-Palomo, L., Vegas‐Gomez, L., Sánchez‐Mejías, E., Trujillo‐Estrada, L., García‐León, J. A., Moreno‐González, I., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105404 · Cited by 136
Zhang, S., Zhu, R., Pan, B., Xu, H. W., Olufemi, M. F., Gathagan, R. J., Li, Y., Zhang, L., Zhang, J., Xiang, W., et al. (2023) · Nature Neuroscience · doi:10.1038/s41593-022-01239-7 · Cited by 131
Weickenmeier, J., Jucker, M., Goriely, A., & Ellen Kuhl, A. (2018) · Journal of the Mechanics and Physics of Solids · doi:10.1016/j.jmps.2018.10.013 · Cited by 126
Self-citationPetrović, S., Arsić, A., Ristić-Medić, D., Cvetković, Z., & Vučić, V. (2020) · Antioxidants · doi:10.3390/antiox9111128 · Cited by 123
The Wnt/Ca2+ pathway is involved in interneuronal communication mediated by tunneling nanotubes
Vargas, J., Loría, F., Wu, Y.-J., Córdova, G., Nonaka, T., Bellow, S., Syan, S., Hasegawa, M., van Woerden, G. M., Trollet, C., et al. (2019) · The EMBO Journal · doi:10.15252/embj.2018101230 · Cited by 123
Gonçalves, P. B., Sodero, A. C. R., & Cordeiro, Y. (2021) · Biomolecules · doi:10.3390/biom11050767 · Cited by 115
Biomimetic carbon nanotubes for neurological disease therapeutics as inherent medication
Xiang, C., Zhang, Y., Guo, W., & Liang, X. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.11.003 · Cited by 114
Imaging transcriptomics of brain disorders
Arnatkeviciute, A., Fulcher, B. D., Bellgrove, M. A., & Fornito, A. (2022) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2021.10.002 · Cited by 113
Iatrogenic Alzheimer’s disease in recipients of cadaveric pituitary-derived growth hormone
Banerjee, G., Farmer, S. F., Hyare, H., Jaunmuktane, Z., Mead, S., Ryan, N. S., Schott, J. M., Werring, D. J., Rudge, P., & Collinge, J. (2024) · Nature Medicine · doi:10.1038/s41591-023-02729-2 · Cited by 115
Brain Shape Changes Associated With Cerebral Atrophy in Healthy Aging and Alzheimer’s Disease
Blinkouskaya, Y., & Weickenmeier, J. (2021) · Frontiers in Mechanical Engineering · doi:10.3389/fmech.2021.705653 · Cited by 125
The prion-like spreading of α-synuclein: From in vitro to in vivo models of Parkinson’s disease
Vargas, J., Grudina, C., & Zurzolo, C. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.01.012 · Cited by 112
Focusing on mitochondria in the brain: from biology to therapeutics
Song, N., Mei, S., Wang, X.-X., Hu, G., & Lu, M. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00409-w · Cited by 111
Hyperphosphorylation Renders Tau Prone to Aggregate and to Cause Cell Death
Liu, M., Sui, D., Dexheimer, T. S., Hovde, S., Deng, X., Wang, K., Lin, H. L., Hagar, H. C., Kweon, H. K., Kuo, N. S., et al. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02034-w · Cited by 98
Cell-Nonautonomous Regulation of Proteostasis in Aging and DiseasePreprint
Morimoto, R. I. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a034074 · Cited by 98
Walker, L. C. (2020) · Free Neuropathology · doi:10.17879/freeneuropathology-2020-3025 · Cited by 113
Self-citationReid, M. J., Beltran-Lobo, P., Johnson, L., Perez‐Nievas, B. G., & Noble, W. J. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.572850 · Cited by 98
Brain connectomics: time for a molecular imaging perspective?
Sala, A., Lizarraga, A., Caminiti, S. P., Calhoun, V. D., Eickhoff, S. B., Habeck, C. G., Jamadar, S. D., Perani, D., Pereira, J. B., Veronese, M., et al. (2023) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2022.11.015 · Cited by 92
Protein-protein interactions in neurodegenerative diseases: A conspiracy theory
Thompson, T., Chaggar, P., Ellen Kuhl, A., Goriely, A., & Initiative, A. D. N. (2020) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008267 · Cited by 97
Xiang, S., Ji, J.-L., Li, S., Cao, X.-P., Xu, W., Tan, L., & Tan, C.-C. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.730036 · Cited by 89
Alternative systems for misfolded protein clearance: life beyond the proteasome
Johnston, H. E., & Samant, R. S. (2020) · FEBS Journal · doi:10.1111/febs.15617 · Cited by 93
Uhlmann, R. E., Rother, C., Rasmussen, J., Schelle, J., Bergmann, C., Ullrich Gavilanes, E. M., Fritschi, S. K., Buehler, A., Baumann, F., Skodras, A., et al. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-00737-w · Cited by 87
Self-citationTauopathies: Deciphering Disease Mechanisms to Develop Effective Therapies
Silva, M. C., & Haggarty, S. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21238948 · Cited by 89
The AAA+ chaperone VCP disaggregates Tau fibrils and generates aggregate seeds in a cellular system
Saha, I., Yuste‐Checa, P., Padilha, M. D. S., Guo, Q., Körner, R., Holthusen, H., Trinkaus, V. A., Dudanova, I., Fernández‐Busnadiego, R., Baumeister, W. P., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36058-2 · Cited by 93
Evidence of distinct α-synuclein strains underlying disease heterogeneity
Holec, S. A. M., & Woerman, A. L. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02163-5 · Cited by 91
Role of Ubiquitin–Proteasome and Autophagy-Lysosome Pathways in α-Synuclein Aggregate Clearance
Sahoo, S., Padhy, A. A., Kumari, V., & Mishra, P. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02897-1 · Cited by 82
Uemura, N., Uemura, M. T., Lo, A., Bassil, F., Zhang, B., Luk, K. C., Lee, V. M. ‐., Takahashi, R., & Trojanowski, J. Q. (2019) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlz070 · Cited by 86
Courte, J., Bousset, L., von Boxberg, Y., Villard, C., Melki, R., & Peyrin, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-61757-x · Cited by 83
The extracellular chaperone Clusterin enhances Tau aggregate seeding in a cellular model
Yuste‐Checa, P., Trinkaus, V. A., Riera-Tur, I., Imamoglu, R., Schaller, T., Wang, H., Dudanova, I., Hipp, M. S., Bracher, A., & Hartl, F. U. (2021) · Nature Communications · doi:10.1038/s41467-021-25060-1 · Cited by 78
Alpha-Synuclein Contribution to Neuronal and Glial Damage in Parkinson’s Disease
Saramowicz, K., Siwecka, N., Galita, G., Kucharska-Lusina, A., Rozpędek‐Kamińska, W., & Majsterek, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010360 · Cited by 79
LAG3 is not expressed in human and murine neurons and does not modulate α‐synucleinopathies
Emmenegger, M., Cecco, E. D., Hruška-Plocháň, M., Eninger, T., Schneider, M. M., Barth, M., Tantardini, E., Rossi, P. D., Bacioglu, M., Langston, R. G., et al. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202114745 · Cited by 76
Self-citationSerpin Signatures in Prion and Alzheimer’s Diseases
Zattoni, M., Mearelli, M., Vanni, S., Baldeschi, A. C., Tran, T. H., Ferracin, C., Catania, M., Moda, F., Fede, G. D., Giaccone, G., et al. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02817-3 · Cited by 75
Liu, S., Hossinger, A., Heumüller, S.-E., Hornberger, A., Buravlova, O., Konstantoulea, K., Müller, S. A., Paulsen, L., Rousseau, F., Schymkowitz, J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25855-2 · Cited by 72
The NLRP3 inflammasome modulates tau pathology and neurodegeneration in a tauopathy model
Stancu, I. C., Lodder, C., Botella Lucena, P., Vanherle, S., Gutiérrez de Ravé, M., Terwel, D., Bottelbergs, A., & Dewachter, I. (2022) · Glia · doi:10.1002/glia.24160 · Cited by 72
Potential human transmission of amyloid β pathology: surveillance and risks
Lauwers, E., Lalli, G., Brandner, S., Collinge, J., Compernolle, V., Duyckaerts, C. J., Edgren, G., Haïk, S., Hardy, J., Helmy, A. E., et al. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30238-6 · Cited by 76
Self-citationTherapy for Alzheimer’s disease: Missing targets and functional markers?
Stoiljković, M., Horváth, T. L., & Hajós, M. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101318 · Cited by 74
Sternburg, E. L., da Silva, L. A. G., & Dormann, D. (2021) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2021.07.004 · Cited by 76
Organotypic slice culture model demonstrates inter-neuronal spreading of alpha-synuclein aggregates
Elfarrash, S., Jensen, N. M., Ferreira, N., Betzer, C., Thevathasan, J. V., Diekmann, R., Adel, M., Omar, N. M., Boraie, M. Z., Gad, S., et al. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0865-5 · Cited by 70
Cell‐to‐cell transmission of C9orf72 poly‐(Gly‐Ala) triggers key features of ALS/FTD
Khosravi, B., LaClair, K. D., Riemenschneider, H., Zhou, Q., Frottin, F., Mareljic, N., Czuppa, M., Farny, D., Hartmann, H., Michaelsen, M., et al. (2020) · The EMBO Journal · doi:10.15252/embj.2019102811 · Cited by 70
Mechanisms Linking Mitochondrial Dysfunction and Proteostasis Failure
Lu, B., & Guo, S. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2020.01.008 · Cited by 69
Chang, Y.-H., & Dubnau, J. (2019) · Current Biology · doi:10.1016/j.cub.2019.07.071 · Cited by 68
The Human Hippocampus in Parkinson’s Disease: An Integrative Stereological and Proteomic Study
Villar‐Conde, S., Astillero‐Lopez, V., González-Rodríguez, M., Villanueva‐Anguita, P., Saiz‐Sánchez, D., Martı́nez-Marcos, A., Flores‐Cuadrado, A., & Úbeda‐Bañón, I. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-202465 · Cited by 68
Resting-state global brain activity affects early β-amyloid accumulation in default mode network
Han, F., Liu, X., Mailman, R. B., Huang, X., Liu, X., & Initiative, T. A. D. N. (2023) · Nature Communications · doi:10.1038/s41467-023-43627-y · Cited by 68
Non-polyphenolic natural inhibitors of amyloid aggregation
Ma, L., Yang, C., Zheng, J., Chen, Y., Xiao, Y., & Huang, K. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112197 · Cited by 66
Brain atrophy progression in Parkinson’s disease is shaped by connectivity and local vulnerability
Tremblay, C., Rahayel, S., Vo, A., Morys, F., Shafiei, G., Abbasi, N., Markello, R. D., Gan‐Or, Z., Mišić, B., & Dagher, A. (2021) · Brain Communications · doi:10.1093/braincomms/fcab269 · Cited by 70
Garcia, P., Jürgens‐Wemheuer, W., Uriarte Huarte, O., Michelucci, A., Masuch, A., Brioschi, S., Weihofen, A., Koncina, E., Coowar, D., Heurtaux, T., et al. (2022) · Glia · doi:10.1002/glia.24149 · Cited by 65
Ji, Y., Chen, X., Wang, Z., Meek, C. J., McLean, J. L., Yang, Y., Yuan, C., Rochet, J., Liu, F., & Xu, R. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03041-w · Cited by 74
Differentially targeted seeding reveals unique pathological alpha-synuclein propagation patterns
Rahayel, S., Mišić, B., Zheng, Y., Liu, Z.-Q., Abdelgawad, A. A., Abbasi, N., Caputo, A., Zhang, B., Lo, A., Kehm, V. M., et al. (2021) · Brain · doi:10.1093/brain/awab440 · Cited by 67
Molecular mechanisms of amyloid formation in living systems
Sinnige, T. (2022) · Chemical Science · doi:10.1039/d2sc01278b · Cited by 67
DNAJC proteins and pathways to parkinsonism
Roosen, D. A., Blauwendraat, C., Cookson, M., & Lewis, P. A. (2019) · FEBS Journal · doi:10.1111/febs.14936 · Cited by 63
Progress of immunotherapy of anti-α-synuclein in Parkinson’s disease
Wang, Z., Gao, G., Duan, C., & Yang, H. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108843 · Cited by 62
Rimal, S., Li, Y., Vartak, R. S., Geng, J., Tantray, I., Li, S., Huh, S., Vogel, H. S., Glabe, C. G., Grinberg, L. T., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01268-6 · Cited by 60
Mixing Aβ(1–40) and Aβ(1–42) peptides generates unique amyloid fibrils
Cerofolini, L., Ravera, E., Bologna, S., Wiglenda, T., Böddrich, A., Purfürst, B., Benilova, I., Korsak, M., Gallo, G., Rizzo, D., et al. (2020) · Chemical Communications · doi:10.1039/d0cc02463e · Cited by 60
Binette, A. P., Theaud, G., Rheault, F., Roy, M., Collins, D. L., Levin, J., Mori, H., Lee, J. H., Farlow, M. R., Schofield, P. R., et al. (2021) · eLife · doi:10.7554/elife.62929 · Cited by 60
Liu, S., Gao, J., Liu, K., & Zhang, H. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111560 · Cited by 59
Viruses in neurodegenerative diseases: More than just suspects in crimes
Leblanc, P., & Vorberg, I. M. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010670 · Cited by 58
Inflammation promotes synucleinopathy propagation
Kim, T.-K., Bae, E.-J., Jung, B. C., Choi, M.-S., Shin, S. J., Park, S. J., Kim, J. T., Jung, M. K., Ulusoy, A., Song, M., et al. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00895-w · Cited by 61
The Cell Biology of Tau Secretion
Merezhko, M., Uronen, R., & Huttunen, H. J. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.569818 · Cited by 65
Amyloid-β-targeting immunotherapies for Alzheimer's disease
Jin, Y., Du, Q., Song, M., Kang, R., Zhou, J., Zhang, H., & Ding, Y. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.09.012 · Cited by 60
Fornari, S., Schäfer, A., Ellen Kuhl, A., & Goriely, A. (2019) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2019.110102 · Cited by 62
Lau, H. H. C., Ingelsson, M., & Watts, J. C. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02201-2 · Cited by 57
Liu, M., Dexheimer, T. S., Sui, D., Hovde, S., Deng, X., Kwok, R. P. S., Bochar, D. A., & Kuo, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-73680-2 · Cited by 59
Protein amyloid aggregate: Structure and function
Xu, Q., Ma, Y., Sun, Y., Li, D., Zhang, X., & Liu, C. (2023) · Aggregate · doi:10.1002/agt2.333 · Cited by 57
Venkataraman, L., Fair, S. R., McElroy, C. A., Hester, M. E., & Fu, H. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-020-10068-9 · Cited by 55
Intercellular Communication in the Brain through Tunneling Nanotubes
Khattar, K. E., Safi, J., Rodriguez, A., & Vignais, M. (2022) · Cancers · doi:10.3390/cancers14051207 · Cited by 54
The evolving landscape of Alzheimer’s disease therapy: From Aβ to tau
Courade, J., Zetterberg, H., Höglinger, G. U., & Dewachter, I. (2025) · Cell · doi:10.1016/j.cell.2025.11.033 · Cited by 57
Gray matter T1‐w/T2‐w ratios are higher in Alzheimer's disease
Pelkmans, W., Dicks, E., Barkhof, F., Vrenken, H., Scheltens, P., van der Flier, W. M., & Tijms, B. M. (2019) · Human Brain Mapping · doi:10.1002/hbm.24638 · Cited by 53
Tanriöver, G., Bacioglu, M., Schweighauser, M., Mahler, J., Wegenast‐Braun, B. M., Skodras, A., Obermüller, U., Barth, M., Kronenberg‐Versteeg, D., Nilsson, K. P. R., et al. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-00993-8 · Cited by 50
Self-citationChang, Y.-H., & Dubnau, J. (2023) · Nature Communications · doi:10.1038/s41467-023-36649-z · Cited by 49
Mathew, B., Mansuri, M. S., Williams, K. R., & Nairn, A. C. (2021) · Brain Sciences · doi:10.3390/brainsci11020258 · Cited by 50
Turano, E., Scambi, I., Virla, F., Bonetti, B., & Mariotti, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032917 · Cited by 50
Yang, F., Zheng, C., Zhang, Y., Xing, C., Cai, W., Li, R., Chen, J., & Duan, Y.-Y. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/6527638 · Cited by 50
Medin aggregation causes cerebrovascular dysfunction in aging wild-type mice
Degenhardt, K., Wagner, J., Skodras, A., Candlish, M., Koppelmann, A. J., Wild, K., Maxwell, R., Rotermund, C., von Zweydorf, F., Gloeckner, C. J., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2011133117 · Cited by 48
Self-citationSuper-resolution imaging reveals α-synuclein seeded aggregation in SH-SY5Y cells
Sang, J. C., Hidari, E., Meisl, G., Ranasinghe, R. T., Spillantini, M. G., & Klenerman, D. (2021) · Communications Biology · doi:10.1038/s42003-021-02126-w · Cited by 48
What Is the Evidence that Parkinson’s Disease Is a Prion Disorder, Which Originates in the Gut?
Kujawska, M., & Jodynis‐Liebert, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113573 · Cited by 48
Metadata
- Authors
- Jucker, M., & Walker, L. C.
- Affiliations
- German Center for Neurodegenerative Diseases (DE)
- Emory University (US)
- Corresponding author
- Jucker, Mathias
- Walker, Lary C.
- Venue
- Nature Neuroscience
- Published
- 2018-09-26
- Volume
- 21
- Issue
- 10
- Pages
- 1341-1349
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- PMC
- PMC6375686
- OpenAlex
- W2891544369
- Cited by
- 450
- References
- 154
- Citations by year
- 2026: 50 · 2025: 69 · 2024: 41 · 2023: 59 · 2022: 51 · 2021: 70 · 2020: 66 · 2019: 40 · 2018: 4
- FWCI
- 4.41
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- DZNE Pub (submittedVersion)
- Funders
- National Institutes of Health (P51OD011132)
- National Institute on Aging (P50AG025688)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Keywords
- neurodegenerative diseases, protein aggregation, prion-like seeding, protein misfolding, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, seed propagation, neurodegeneration, host-pathogen interaction
- MeSH terms
- Animals, Cell Communication, Humans, Prions, Neurodegenerative Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
